Chase DeQuinn Sullivan

Chase Sullivan serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions in support of scientific and technical research initiatives. He ensures compliance with federal procurement regulations while facilitating timely and efficient contract award and administration processes. His work is central to advancing mission-critical R&D efforts across life sciences and engineering domains, with a focus on securing innovative solutions through competitive, transparent, and compliant contracting practices. He routinely handles complex service-based acquisitions requiring technical evaluation, performance-based specifications, and stringent oversight to meet federal research objectives. Chase collaborates with a diverse range of contractors, including research institutions, independent scientific consultants, and mid-to-large-sized firms specializing in biotechnology and applied sciences. His procurement approach emphasizes merit-based selection, rigorous source evaluation, and performance metrics aligned with technical deliverables. While no single contractor dominates his portfolio, he maintains consistent relationships with vendors possessing proven expertise in laboratory automation, data analytics, and experimental design services, fostering long-term partnerships grounded in accountability and innovation. Chase’s contracting patterns reflect a strong preference for open competition, with 100% of his awards issued under non-set-aside procedures. This indicates a deliberate focus on selecting the most technically qualified offerors regardless of socioeconomic status, prioritizing capability and scientific rigor over programmatic set-asides. While he does not routinely utilize 8(a), HUBZone, or SDVOSB programs, his approach remains fully compliant with all small business participation goals, ensuring fair access for all eligible vendors without compromising technical standards. His primary procurement focus lies in NAICS 541714 (Biotechnology R&D), 541715 (Physical, Engineering, and Life Sciences R&D), and 541712 (Life Sciences R&D excluding Biotechnology), reflecting deep expertise in procuring advanced research services such as clinical trial design, molecular analysis, and computational modeling. He specializes in acquiring high-complexity scientific services requiring specialized instrumentation, regulatory compliance, and peer-reviewed methodology, positioning him as a key liaison between federal research goals and the private-sector innovation ecosystem.